Disease/Infection News

RSS

The promise of RNA medicine is targeted and personalized

The development of messenger RNA (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has only increased the impetus in this field.

11 May 2022

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

Many doctors caution their pregnant patients to avoid cat feces; even the family pet's litter box is off-limits. Now, a group of researchers from Clemson University have discovered a promising therapy for those who suffer from toxoplasmosis, a disease caused by the microscopic protozoa Toxoplasma gondii.

11 May 2022

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

The MRC/UVRI and LSHTM Uganda Research Unit has unveiled a new state-of-the-art clinical research facility in Entebbe to further boost its contributions to science, policy and practice in Uganda.

11 May 2022

Discovery of host co-factors necessary for SARS-CoV2 infection

A new study published in the journal EMBO Reports has reported on the shedding of two proteases, namely, ADAM10 and ADAM17, which aids in S protein-dependent molecular events.

11 May 2022

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

Researchers at the University of Maryland School of Medicine (UMSOM) have been collaborating on an extensive heart registry that includes student-athletes in the Big Ten athletic conference, to learn more about cardiac issues in those who have recovered from a COVID-19 infection.

11 May 2022

Direct influenza infection of the heart drives cardiac complications, study reveals

Researchers have shown for the first time in mice that heart problems associated with the flu are not caused by raging inflammation in the lungs, as has long been predicted.

11 May 2022

COVID-19 patients with persistent viral shedding may warrant closer surveillance and monitoring for complications

A new Northwestern Medicine study published in GeroScience sought to determine the prevalence, risk factors and significance of persistent viral shedding in hospitalized COVID-19 patients.

11 May 2022

First oral antiviral approved for early treatment of COVID-19

The United States Food and Drug Administration granted an Emergency Use Authorization in December 2021 for the first oral antiviral, a pill containing two protease inhibitors – nirmatrelvir and ritonavir (Paxlovid, Pfizer) – for early treatment of COVID-19.

11 May 2022

Unique binding property may explain the ability of delta variant to spread more rapidly

Unlike other SARS-CoV-2 variants, the Delta variant can attach to copies of itself, forming larger aggregations, or clumps, of viral particles, suggests a study by scientists at the National Institutes of Health.

11 May 2022

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Researchers reviewed messenger ribonucleic acid (mRNA) technology and highlighted its clinical applications.

11 May 2022

Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

Researchers depicted the efficacy of the SARS-CoV-2 monoclonal antibodies (mAbs) against the SARS-CoV-2 Omicron variant.

11 May 2022

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

A new study explored key vaccine features which could help induce and preserve humoral immunity against SARS-CoV-2 infection.

11 May 2022

Association between physical activity paradox and risk variables for cardiovascular disease

In a new study, investigators analyzed the significance of the physical activity paradox in the risk variables for cardiovascular disease (CVD).

11 May 2022

How is the Antimicrobial Resistance Crisis Impacting Sepsis?

In this interview, News-Medical talks to Dr. Ron Daniels about his work at the UK Sepsis Trust and the impact antimicrobial resistance is having on sepsis.

11 May 2022

Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

Researchers demonstrated that four SARS-CoV-2 Omicron sub-lineages, BA.1, BA.1.1, BA.2, and BA.3, are resistant to current COVID-19 vaccines and antibody therapeutics to varying extents.

11 May 2022

COVID-19-induced non-cell-autonomous anosmia

Researchers reported that SARS-CoV-2-induced anosmia was based on non-cell-independent processes.

11 May 2022

Exploring routine saliva testing for SARS-CoV-2 in children

The focus of a recent study was to implement a weekly SARS-CoV-2 saliva testing schedule in childcare centers.

11 May 2022

New research on excess mortality in the Nordics during COVID

Both from a scientific and a political standpoint, it is important to record and examine the additional deaths during the ongoing coronavirus disease 2019 (COVID-19) pandemic.

11 May 2022

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

Assessment of England's medication prescribing safety during COVID pandemic

In a recent study posted to the medRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on the prescribing safety of high-risk medications on a national scale in England.

11 May 2022

Disease/Infection News

The promise of RNA medicine is targeted and personalized

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

Discovery of host co-factors necessary for SARS-CoV2 infection

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

Direct influenza infection of the heart drives cardiac complications, study reveals

COVID-19 patients with persistent viral shedding may warrant closer surveillance and monitoring for complications

First oral antiviral approved for early treatment of COVID-19

Unique binding property may explain the ability of delta variant to spread more rapidly

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

Association between physical activity paradox and risk variables for cardiovascular disease

How is the Antimicrobial Resistance Crisis Impacting Sepsis?

Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

COVID-19-induced non-cell-autonomous anosmia

Exploring routine saliva testing for SARS-CoV-2 in children

New research on excess mortality in the Nordics during COVID

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Assessment of England's medication prescribing safety during COVID pandemic

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News